ID   KKCC1_RAT               Reviewed;         505 AA.
AC   P97756; Q64572; Q794E3;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   24-JUL-2024, entry version 158.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase kinase 1;
DE            Short=CaM-KK 1;
DE            Short=CaM-kinase kinase 1;
DE            Short=CaMKK 1;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM-kinase IV kinase;
DE   AltName: Full=Calcium/calmodulin-dependent protein kinase kinase alpha;
DE            Short=CaM-KK alpha;
DE            Short=CaM-kinase kinase alpha;
DE            Short=CaMKK alpha;
GN   Name=Camkk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 214-230 AND 291-310,
RP   FUNCTION, ACTIVITY REGULATION, INTERACTION WITH CALMODULIN, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7642608; DOI=10.1074/jbc.270.33.19320;
RA   Tokumitsu H., Enslen H., Soderling T.R.;
RT   "Characterization of a Ca2+/calmodulin-dependent protein kinase cascade.
RT   Molecular cloning and expression of calcium/calmodulin-dependent protein
RT   kinase kinase.";
RL   J. Biol. Chem. 270:19320-19324(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8827455; DOI=10.1093/oxfordjournals.jbchem.a021365;
RA   Okuno S., Kitani T., Fujisawa H.;
RT   "Evidence for the existence of Ca2+/calmodulin-dependent protein kinase IV
RT   kinase isoforms in rat brain.";
RL   J. Biochem. 119:1176-1181(1996).
RN   [3]
RP   PROTEIN SEQUENCE OF 4-13; 20-38; 50-60; 137-148; 196-210; 275-288; 291-311;
RP   333-340; 351-360; 365-382; 389-397; 405-408; 440-444; 458-468 AND 473-478,
RP   FUNCTION IN PHOSPHORYLATION OF CAMK1 AND CAMK4, AND AUTOPHOSPHORYLATION.
RX   PubMed=8631893; DOI=10.1074/jbc.271.18.10806;
RA   Edelman A.M., Mitchelhill K.I., Selbert M.A., Anderson K.A., Hook S.S.,
RA   Stapleton D., Goldstein E.G., Means A.R., Kemp B.E.;
RT   "Multiple Ca(2+)-calmodulin-dependent protein kinase kinases from rat
RT   brain. Purification, regulation by Ca(2+)-calmodulin, and partial amino
RT   acid sequence.";
RL   J. Biol. Chem. 271:10806-10810(1996).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=8929978; DOI=10.1016/0304-3940(96)12317-x;
RA   Nakamura Y., Okuno S., Kitani T., Otake K., Sato F., Fujisawa H.;
RT   "Distribution of Ca2+/calmodulin-dependent protein kinase kinase alpha in
RT   the rat central nervous system: an immunohistochemical study.";
RL   Neurosci. Lett. 204:61-64(1996).
RN   [5]
RP   CHARACTERIZATION, AND REGION.
RX   PubMed=9335539; DOI=10.1021/bi971348i;
RA   Tokumitsu H., Wayman G.A., Muramatsu M.-A., Soderling T.R.;
RT   "Calcium/calmodulin-dependent protein kinase kinase: identification of
RT   regulatory domains.";
RL   Biochemistry 36:12823-12827(1997).
RN   [6]
RP   PHOSPHORYLATION AT THR-108 AND SER-458, MUTAGENESIS OF THR-108 AND SER-458,
RP   AND PHOSPHORYLATION BY PRCAKA.
RX   PubMed=9195898; DOI=10.1074/jbc.272.26.16073;
RA   Wayman G.A., Tokumitsu H., Soderling T.R.;
RT   "Inhibitory cross-talk by cAMP kinase on the calmodulin-dependent protein
RT   kinase cascade.";
RL   J. Biol. Chem. 272:16073-16076(1997).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF AKT1.
RX   PubMed=9859994; DOI=10.1038/25147;
RA   Yano S., Tokumitsu H., Soderling T.R.;
RT   "Calcium promotes cell survival through CaM-K kinase activation of the
RT   protein-kinase-B pathway.";
RL   Nature 396:584-587(1998).
RN   [8]
RP   PHOSPHORYLATION AT SER-74 AND THR-108, MUTAGENESIS OF SER-74 AND THR-108,
RP   PHOSPHORYLATION BY PRCAKA, AND TISSUE SPECIFICITY.
RX   PubMed=10187789; DOI=10.1074/jbc.274.15.10086;
RA   Matsushita M., Nairn A.C.;
RT   "Inhibition of the Ca2+/calmodulin-dependent protein kinase I cascade by
RT   cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 274:10086-10093(1999).
RN   [9]
RP   MUTAGENESIS OF ARG-172 AND ARG-177, DOMAIN RP, AND INTERACTION WITH CAMK4.
RX   PubMed=10336483; DOI=10.1074/jbc.274.22.15803;
RA   Tokumitsu H., Takahashi N., Eto K., Yano S., Soderling T.R.,
RA   Muramatsu M.-A.;
RT   "Substrate recognition by Ca2+/Calmodulin-dependent protein kinase kinase.
RT   Role of the arg-pro-rich insert domain.";
RL   J. Biol. Chem. 274:15803-15810(1999).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10651863; DOI=10.1046/j.1460-9568.2000.00883.x;
RA   Sakagami H., Umemiya M., Saito S., Kondo H.;
RT   "Distinct immunohistochemical localization of two isoforms of
RT   Ca2+/calmodulin-dependent protein kinase kinases in the adult rat brain.";
RL   Eur. J. Neurosci. 12:89-99(2000).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458 AND SER-475, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   STRUCTURE BY NMR OF 438-463 IN COMPLEX WITH CA(2+)/CALMODULIN, MUTAGENESIS
RP   OF PHE-459 AND PHE-463, AND REGION.
RX   PubMed=10467092; DOI=10.1038/12271;
RA   Osawa M., Tokumitsu H., Swindells M.B., Kurihara H., Orita M.,
RA   Shibanuma T., Furuya T., Ikura M.;
RT   "A novel target recognition revealed by calmodulin in complex with Ca2+-
RT   calmodulin-dependent kinase kinase.";
RL   Nat. Struct. Biol. 6:819-824(1999).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that belongs to a
CC       proposed calcium-triggered signaling cascade involved in a number of
CC       cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4.
CC       Involved in regulating cell apoptosis. Promotes cell survival by
CC       phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-
CC       antagonist of cell death. {ECO:0000269|PubMed:7642608,
CC       ECO:0000269|PubMed:8631893, ECO:0000269|PubMed:9859994}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17;
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin may relieve intrasteric autoinhibition. Partially inhibited
CC       upon phosphorylation by PRCAKA/PKA. May be regulated through
CC       phosphorylation by CAMK1 and CAMK4. {ECO:0000269|PubMed:7642608}.
CC   -!- SUBUNIT: Interacts with CAMK4 and calmodulin.
CC       {ECO:0000269|PubMed:10336483, ECO:0000269|PubMed:10467092,
CC       ECO:0000269|PubMed:7642608}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- TISSUE SPECIFICITY: Mostly expressed in the brain with higher levels in
CC       cortex and hippocampus. Lower expression levels were detected in
CC       striatum, nucleus accumbens and cerebellum (at protein level). Abundant
CC       in forebrain, weaker in cerebellum and also detected in thymus and
CC       spleen. {ECO:0000269|PubMed:10187789, ECO:0000269|PubMed:7642608}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin binding
CC       region and may be involved in intrasteric autoinhibition.
CC       {ECO:0000269|PubMed:10336483}.
CC   -!- DOMAIN: The RP domain (arginine/proline-rich) is involved in the
CC       recognition of CAMKI and CAMK4 as substrates.
CC       {ECO:0000269|PubMed:10336483}.
CC   -!- PTM: Appears to be autophosphorylated. Phosphorylated at multiple sites
CC       by PRCAKA/PKA. Phosphorylation of Ser-458 is blocked upon binding to
CC       Ca(2+)/calmodulin. May be phosphorylated by CAMK1 and CAMK4.
CC       {ECO:0000269|PubMed:10187789, ECO:0000269|PubMed:9195898}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L42810; AAC42070.1; -; mRNA.
DR   EMBL; AB023658; BAA75246.1; -; mRNA.
DR   EMBL; S83194; AAB46910.1; -; mRNA.
DR   PIR; A57156; A57156.
DR   RefSeq; NP_113850.1; NM_031662.1.
DR   PDB; 1CKK; NMR; -; B=438-463.
DR   PDBsum; 1CKK; -.
DR   AlphaFoldDB; P97756; -.
DR   BMRB; P97756; -.
DR   SMR; P97756; -.
DR   BioGRID; 248789; 3.
DR   IntAct; P97756; 4.
DR   MINT; P97756; -.
DR   STRING; 10116.ENSRNOP00000025009; -.
DR   iPTMnet; P97756; -.
DR   PhosphoSitePlus; P97756; -.
DR   PaxDb; 10116-ENSRNOP00000025009; -.
DR   Ensembl; ENSRNOT00055047594; ENSRNOP00055039163; ENSRNOG00055027466.
DR   Ensembl; ENSRNOT00060032174; ENSRNOP00060026187; ENSRNOG00060018674.
DR   Ensembl; ENSRNOT00065043172; ENSRNOP00065035370; ENSRNOG00065025095.
DR   GeneID; 60341; -.
DR   KEGG; rno:60341; -.
DR   AGR; RGD:62023; -.
DR   CTD; 84254; -.
DR   RGD; 62023; Camkk1.
DR   eggNOG; KOG0585; Eukaryota.
DR   InParanoid; P97756; -.
DR   OrthoDB; 5489318at2759; -.
DR   PhylomeDB; P97756; -.
DR   BRENDA; 2.7.11.17; 5301.
DR   Reactome; R-RNO-111932; CaMK IV-mediated phosphorylation of CREB.
DR   Reactome; R-RNO-442729; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde.
DR   Reactome; R-RNO-9619229; Activation of RAC1 downstream of NMDARs.
DR   EvolutionaryTrace; P97756; -.
DR   PRO; PR:P97756; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   IDEAL; IID50177; -.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24346:SF77; CALCIUM_CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1; 1.
DR   PANTHER; PTHR24346; MAP/MICROTUBULE AFFINITY-REGULATING KINASE; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calmodulin-binding; Cytoplasm;
KW   Direct protein sequencing; Kinase; Methylation; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..505
FT                   /note="Calcium/calmodulin-dependent protein kinase kinase
FT                   1"
FT                   /id="PRO_0000086143"
FT   DOMAIN          128..409
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          27..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          167..189
FT                   /note="RP domain"
FT                   /evidence="ECO:0000269|PubMed:10336483"
FT   REGION          435..440
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000269|PubMed:10336483,
FT                   ECO:0000269|PubMed:9335539"
FT   REGION          438..463
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:10467092,
FT                   ECO:0000269|PubMed:9335539"
FT   REGION          460..505
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        275
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         134..142
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         157
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N5S9"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10187789"
FT   MOD_RES         78
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VBY2"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VBY2"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:10187789,
FT                   ECO:0000269|PubMed:9195898"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:9195898,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N5S9"
FT   MUTAGEN         74
FT                   /note="S->A: Decrease in phosphorylation by PKA."
FT                   /evidence="ECO:0000269|PubMed:10187789"
FT   MUTAGEN         108
FT                   /note="T->A: Decrease in phosphorylation and partial
FT                   inhibition by PKA. Almost loss of inhibition by PKA; when
FT                   associated with A-458."
FT                   /evidence="ECO:0000269|PubMed:10187789,
FT                   ECO:0000269|PubMed:9195898"
FT   MUTAGEN         172
FT                   /note="R->E: Loss of substrate recognition and interaction
FT                   with CAMK4."
FT                   /evidence="ECO:0000269|PubMed:10336483"
FT   MUTAGEN         177
FT                   /note="R->E: Loss of substrate recognition and interaction
FT                   with CAMK4."
FT                   /evidence="ECO:0000269|PubMed:10336483"
FT   MUTAGEN         458
FT                   /note="S->A: Decrease in phosphorylation and partial
FT                   inhibition by PKA. Almost loss of inhibition by PKA; when
FT                   associated with A-108."
FT                   /evidence="ECO:0000269|PubMed:9195898"
FT   MUTAGEN         459
FT                   /note="F->D: Loss of binding to Ca(2+)/calmodulin."
FT                   /evidence="ECO:0000269|PubMed:10467092"
FT   MUTAGEN         463
FT                   /note="F->D: Loss of binding to Ca(2+)/calmodulin."
FT                   /evidence="ECO:0000269|PubMed:10467092"
FT   CONFLICT        45
FT                   /note="P -> S (in Ref. 1; AAC42070)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        81
FT                   /note="G -> E (in Ref. 1; AAC42070)"
FT                   /evidence="ECO:0000305"
FT   HELIX           444..453
FT                   /evidence="ECO:0007829|PDB:1CKK"
FT   STRAND          455..457
FT                   /evidence="ECO:0007829|PDB:1CKK"
SQ   SEQUENCE   505 AA;  55908 MW;  6B268780AC9B67E1 CRC64;
     MERSPAVCCQ DPRAELVERV AAISVAHLEE AEEGPEPASN GVDPPPRARA ASVIPGSASR
     PTPVRPSLSA RKFSLQERPA GSCLEAQVGP YSTGPASHMS PRAWRRPTIE SHHVAISDTE
     DCVQLNQYKL QSEIGKGAYG VVRLAYNERE DRHYAMKVLS KKKLLKQYGF PRRPPPRGSQ
     APQGGPAKQL LPLERVYQEI AILKKLDHVN VVKLIEVLDD PAEDNLYLVF DLLRKGPVME
     VPCDKPFPEE QARLYLRDII LGLEYLHCQK IVHRDIKPSN LLLGDDGHVK IADFGVSNQF
     EGNDAQLSST AGTPAFMAPE AISDTGQSFS GKALDVWATG VTLYCFVYGK CPFIDEYILA
     LHRKIKNEAV VFPEEPEVSE ELKDLILKML DKNPETRIGV SDIKLHPWVT KHGEEPLPSE
     EEHCSVVEVT EEEVKNSVKL IPSWTTVILV KSMLRKRSFG NPFEPQARRE ERSMSAPGNL
     LLKEGCGEGG KSPELPGVQE DEAAS
//
